<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        0403256981
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1989
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        HUMAN ALBUMIN 200G-I TAKEDA
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        ALBUMIN HUMAN
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        20
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Intravenous use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Solution
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        50
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Vial
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Biological
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 25°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        141
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="TAKEDA MANUFACTURING AUSTRIA AG" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            TAKEDA MANUFACTURING AUSTRIA AG
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 583]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            ALNAGHI COMPANY
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Takeda Manufacturing AG
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        B05AA01
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Human Albumin 200 g/l Takeda contains a protein called albumin found in the liquid component of the blood (the plasma) and belongs to the group of medical products called &ldquo;plasma substitutes and plasma protein fractions&rdquo;.<br />It is made from human blood collected from blood donors.<br />A vial of 50 ml contains 10 g of human albumin.<br />A vial of 100 ml contains 20 g of human albumin.<br />Human albumin is used to restore and maintain blood volume in patients who have lost blood or fluid due to certain medical conditions. The choice of albumin rather than an artificial substitute and the dose needed will depend on the clinical situation of the individual patient.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not use Human Albumin 200 g/l Takeda:</strong><br />- if you are allergic to human albumin or any of the other ingredients of this medicine (listed in section 6).</p><p><strong>Take special care with HUMAN ALBUMIN 200 g/l Takeda</strong><br />Talk to your doctor, pharmacist or nurse before using Human Albumin 200 g/l Takeda.<br />- if you think you have an allergic reaction during the treatment, with difficulty breathing, feeling faint or other symptoms. If this happens, tell your doctor or nurse immediately because the infusion will have to be stopped and medical treatment for shock may need to be implemented.<br />- if you have:<br />&ndash; uncontrolled heart failure<br />&ndash; high blood pressure<br />&ndash; oesophageal varices (swollen veins in the oesophagus)<br />&ndash; pulmonary oedema (fluid on the lungs)<br />&ndash; a tendency to spontaneous bleeding<br />&ndash; severe anemia (lack of red blood cells)<br />&ndash; no urine formation.<br />If you think any of these applies to you, inform your doctor so that he/she can take appropriate precautions.<br />When medicines are made from human blood or plasma, certain steps are put in place to prevent infections being passed on to patients. These include careful selection of blood and plasma donors to make sure those at risk of&nbsp;carrying infections are excluded, and the testing of each donation and pools of plasma for signs of virus/infections. Manufacturers of these products also include steps in the processing of the blood or plasma that can inactivate or remove viruses. Despite these measures, when medicines prepared from human blood or plasma are administered, the possibility of passing on infection cannot be totally excluded. This also applies to any unknown or emerging viruses or other types of infections.</p><p>There are no reports of virus infections with albumin manufactured to European Pharmacopoeia specifications by established processes.</p><p>It is strongly recommended that every time you receive a dose of Human Albumin 200 g/l Takeda the name and batch number of the product are recorded in order to maintain a record of the batches used.</p><p>Because this product is made from human blood, it may carry a risk of transmitting infectious agents, e.g., viruses, theoretically, the Creutzfeldt-Jakob disease (CJD) agent. There is also the possibility that unknown infectious agents may be present in such products.</p><p><strong>Other medicines and Human Albumin 200 g/l Takeda</strong><br />- Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.<br />- No specific complications of taking human albumin with other medicinal products are known.<br /><strong>Pregnancy, breast-feeding and fertility</strong><br />If you are pregnant or breast-feeding, think you might be pregnant or are planning to have a baby ask your doctor. Your doctor will decide if you can use Human Albumin 200 g/l Takeda during pregnancy or breastfeeding.<br /><strong>Driving and using machines</strong><br />No effect on the ability to drive or use machines has been observed.<br /><strong>Human Albumin 200 g/l Takeda contains sodium</strong><br /><strong>50 mL vial:</strong><br />This medicinal product contains 115 &ndash; 149.5 mg sodium (main component of cooking/table salt) per vial. This is equivalent to 5.8 &ndash; 7.5 % of the recommended maximum daily intake of 2 g sodium for an adult.<br /><strong>100 mL vial:</strong><br />This medicinal product contains 230 - 299 mg sodium (main component of cooking/table salt) per vial. This is equivalent to 11.5 - 15 % of the recommended maximum daily intake of 2 g sodium for an adult.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Human Albumin 200 g/l Takeda is a medicine for hospital use. It will therefore be administered in a hospital by appropriate health care personnel. Your doctor will establish the amount of product to be administered, the frequency of dosing and the duration of treatment based on your specific condition. He/she will monitor your condition, measuring your blood pressure and heart rate and taking blood tests, while you are receiving Human Albumin to make sure that you are not given too much.<br />If you experience headache, difficulties in breathing or increased blood pressure, please tell your doctor.</p><p><strong>If you take more Human Albumin 200 g/l Takeda than<br />you should</strong><br />If you may have got more Human Albumin 200 g/l Takeda than you should consult your doctor or pharmacist immediately.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them. If any of the side effects listed below occurs, the infusion should be stopped immediately and appropriate treatment initiated:<br />&bull; anaphylactic shock (very rare: may affect up to 1 in<br />10 000 people)<br />&bull; hypersensitivity/allergic reactions (not known: frequency cannot be estimated from the available data)<br />The following side effects have also been reported:<br />Rare: may affect up to 1 in 1,000 people<br />- nausea (feeling sick)<br />- flushing<br />- skin rash<br />- fever</p><p>Other side effects observed after placing Human Albumin on the market are (Not known: frequency cannot be estimated from the available data)<br />- Hypersensitivity reactions.<br />- headache<br />- altered sense of taste<br />- heart attack<br />- irregular heartbeat<br />- rapid heartbeat<br />- abnormally low blood pressure<br />- accumulation of fluid in the lung<br />- breathlessness or breathing discomfort<br />- vomiting<br />- hives<br />- itchiness<br />- chills</p><p>If you get any side effects, talk to your doctor or pharmacist. This includes any side effects not listed in this leaflet.</p><p>Reporting of side effects<br />If you get any side effects, talk to your doctor, pharmacist<br />or nurse. This includes any possible side effects not listed<br />in this leaflet. You can also report side effects directly via:<br />&bull; Saudi Arabia:<br />Please report adverse drug events to:<br />The National Pharmacovigilance Centre (NPC):<br />&bull; SFDA Call Center: 19999<br />&bull; E-mail: npc.drug@sfda.gov.sa<br />&bull; Website: https://ade.sfda.gov.sa</p><p>&bull; Other GCC states:<br />- Please contact the relevant competent authority.</p><p>By reporting side effects you can help provide more information on the safety of this medicine.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep this medicine out of the sight and reach of children.<br />Do not use this medicine after the expiry date which is stated on the label. The expiry date refers to the last day of that month.<br />Do not store above 25&deg;C. Do not freeze.<br />Keep the glass vial in the outer carton in order to protect from light.<br />Once the package has been opened, the contents must be used immediately.<br />Do not use Human Albumin 200 g/l Takeda if you notice the solution is cloudy or has particles in it.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>- The active substance is: human albumin.</p><p>Every 100 ml contain 20 g of total protein, of which at least 95% is human albumin.</p><p><br />- The other ingredients are: sodium chloride, sodium caprylate, sodium N-acetyltryptophanate, water for<br />injection.<br />&nbsp;</p><p>Total amount of sodium ions: 100 &ndash;130 mmol/l</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                It is a clear, slightly thick liquid; it is almost colourless, yellow, amber or green. It is a sterile solution for intravenous infusion in 50 ml or 100 ml glass vials.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Marketing Authorization Holder</strong><br />Takeda Manufacturing Austria AG<br />Vienna, Austria</p><p><strong>Manufacturer</strong><br />Takeda Manufacturing Austria AG<br />Industriestra&szlig;e 67<br />1221 Vienna, Austria</p><p><br />Takeda Manufacturing Italia S.p.A.<br />Via G. B. Oliva, 2 56121 Loc. Ospedaletto, Pisa, Italy</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This leaflet was last revised in March 2022.
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>يحتوي هذا المنتج على بروتين يسمى الألبومين موجود في المكون السائل للدم(البلازما) وينتمي إلى مجموعة من المنتجات الطبية تسمى &quot;بدائل البلازما وأجزاء بروتين البلازما&quot;. وهي مصنوعة من دم بشري تم جمعه من متبرعين بالدم.<br />قارورة سعة 50 ملل تحتوي على 10 جم من الألبومين البشري.<br />قارورة سعة 100 ملل تحتوي على 20 جم من الألبومين البشري.<br />يُستخدم الألبومين البشري لاستعادة حجم الدم والحفاظ عليه في المرضى الذين فقدوا الدم أو السوائل بسبب بعض الحالات الطبية. يُحدَّد اختيار الألبومين بدلاً من بديل اصطناعي - وكذلك اختيار الجرعة اللازمة - حسب الحالة الطبية لكل مريض.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><strong>&nbsp;لا تستخدم الألبومین البشري 200 جم/لتر تاكید</strong></p><p>● إذا كانت لديك حساسية (فرط تحسس) تجاه الألبومين البشري أو أي من المكونات الأخرى في الألبومين البشري 200 جم/لتر تاكيدا. <strong>يجب توخي الحذر مع استخدام الألبومين البشري 200 جم/لتر تاكيدا في الحالات التالية:</strong><br />● إذا كنت تعتقد أنك تعاني من حساسية أثناء العلاج، مع صعوبة في التنفس أو الشعور بالإغماء أو أعراض أخرى. إذا حدث ذلك، فأخبر الطبيب أو اختصاصي التمريض على الفور لأنه سيتعين وقف التسريب، وقد يلزم تنفيذ علاج طبي للصدمة.<br />●إذا كنت مصابًا بما يلي:<br />&ndash; فشل القلب الخارج عن السيطرة<br />&ndash; ارتفاع ضغط الدم<br />&ndash; دوالي المريء (أوردة منتفخة في المريء)<br />&ndash; الوذمة الرئوية (السوائل في الرئتين)<br />&ndash; ميل للنزف العفوي (التلقائي)<br />&ndash; فقر الدم الشديد (نقص خلايا الدم الحمراء)<br />&ndash; شُح البول (قِلَّةُ البَول)</p><p>إذا كنت تعتقد أن أيًّا منها ينطبق عليك، فأخبر الطبيب حتى يمكنه اتخاذ الاحتياطات المناسبة.<br />شائعة جدًا<br />شائعة<br />غير شائعة<br />نادرة<br />نادرة جدًا<br />عندما يتم تصنيع الأدوية من الدم أو البلازما البشرية، يتم اتخاذ بعض التدابير لمنع انتقال العدوى إلى المرضى. وتتضمن هذه الإجراءات انتقاء المتبرعين بالدم والبلازما بدقة للتأكد من استبعاد الأشخاص الحاملين لخطر العدوى، ثم اختبار كل تبرع وتجميعات البلازما بحثًا عن وجود علامات فيروس/عدوى. كما تحرص الشركات المصنعة لهذه المنتجات على إدراج خطوات في عملية معالجة الدم أو البلازما تتيح تعطيل نشاط الفيروسات أو التخلص منها. وعلى الرغم من اتخاذ كل هذه التدابير، إلا أنه عند استخدام الأدوية المُعدّة من الدم أو البلازما البشرية، فلا يمكن استبعاد إمكانية انتقال العدوى تمامًا. وهذا ينطبق أيضًا على أي فيروسات غير معروفة أو مستجدة أو غيرها من أنواع العدوى.</p><p><br />لا تتوفر أي تقارير عن حدوث إصابات بالفيروسات مع الألبومين المصنَّع وفقًا لمواصفات دستور الأدوية الأوروبي من خلال العمليات المثبتة.<br />ويوصى بشدة بتسجيل اسم المنتج ورقم الدفعة في كل مرة تتلقى فيها جرعة من الألبومين البشري 200 جم/لتر تاكيدا&nbsp;للحفاظ على سجل بالدفعات المستخدمة. نظرًا لأن هذا المنتج مصنوع من دم بشري، فقد ينطوي على خطر نقل عوامل مُعْدِية، مثل الفيروسات، ونظريًّا دون توفر حالات مثبتة الإصابة بعامل داء كروتزفيلد جاكوب(CJD) وهناك أيضًا احتمال لوجود عوامل معدية غير معروفة في مثل هذه المنتجات.&nbsp;</p><p><br /><strong>استخدام الأدوية الأخرى</strong><br />● يرجى إبلاغ الطبيب أو الصيدلي إذا كنت تتناول، أو كنت قد تناولت مؤخرًا، أي أدوية أخرى، حتى تلك التي تُصرف دون وصفة طبية.<br />●لا تحدث مضاعفات محددة من تناول الألبومين البشري مع المنتجات الطبية الأخرى معروفة.<br /><strong>الحمل والرضاعة الطبيعية</strong><br />أخبِري الطبيب أو الصيدلي قبل استخدام هذا الدواء إذا كنتِ أو قد تكونين حاملاً أو إذا كنتِ تُرضعين رضاعة طبيعية. سيقرر الطبيب ما إذا كان بإمكانكِ استخدام الألبومين البشري 200 جم/لتر تاكيدا أثناء الحمل أو الرضاعة الطبيعية.<br /><strong>القيادة واستخدام الآلات</strong><br />لا يوجد سبب للاعتقاد بأن الدواء سوف يؤثر على قدرتك على القيادة أو استخدام الآلات.</p><p><strong>الألبومین البشري 200 جم/لتر تاكیدا یحتوي على الصود&nbsp;يوم<br />قارورة سعة 50 مل</strong><br />یحتوي ھذا الدواء على 115 - 149.5 ملغ صودیوم (المكون الرئیسي في ملح الطعام) في كل -&nbsp;قارورة، وھو ما یعادل 5.8 - 7.5 % من الحد الأقصى المُوصَى بھ من الحصة الغذائیة الیومیة - من الصودیوم للشخص البالغ .<br /><strong>قارورة سعة 100 مل</strong><br />- یحتوي ھذا الدواء على 230 - 299 ملغ صودیوم (المكون الرئیسي في ملح الطعام) في كل&nbsp;قارورة، وھو ما یعادل 11.5 - 15 % من الحد الأقصى المُوصَى بھ من الحصة الغذائیة الیومیة - من الصودیوم للشخص البالغ.<br />&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><br />الألبومین البشري 200 جم/لتر تاكیدا ھو دواء للاستخدام في المستشفیات. وبالتالي سیتم إعطاؤه في المستشفى من قِبل أفراد الرعایة الصحیة المناسبین. وسیقوم الطبیب بتحدید كمیة المنتج التي یجب إعطاؤھا ومعدل تكرار الجرعات ومدة العلاج بناءً على حالتك المحددة، حیث سیتابع<br />حالتك ویقیس ضغط الدم ومعدل ضربات القلب ویُجري اختبارات الدم، بینما تتلقى الألبومین البشري للتأكد من أنھ لم یتم إعطاؤك أكثر من اللازم. إذا كنت تعاني من صداع أو صعوبة في التنفس أو زیادة في ضغط الدم، یرجى إبلاغ الطبیب.<br />في حالة تناولك الألبومین البشري 200 جم/لتر تاكیدا أكثر مما ینبغي إذا تلقیت كمیة من الألبومین البشري 200 جم/لتر تاكیدا أكثر مما ینبغي، فاستشر الطبیب أو الصیدلي على الفور.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>يمكن أن يتسبب الألبومين البشري 200 جم/لتر تاكيدا مثل جميع الأدوية في حدوث آثار جانبية، إلا أنه لا يتعرض لها جميع المرضى.</p><p><strong>آثار شائعة جدًا</strong> تحدث لدى أكثر من 1 في كل 10 مرضى تمت معالجتهم<br /><strong>جدًا</strong> تحدث لدى أقل من 1 في كل 10 مرضى ولكن لدى<br />أكثر من 1 في كل 100 مريض تم علاجهم<br /><strong>آثار غير شائعة</strong> تحدث لدى أقل من 1 في كل 100 مرضى ولكن لدى<br />أكثر من 1 في كل 1000 مريض تم علاجهم<br /><strong>آثار نادرة </strong>تحدث لدى أقل من 1 في كل 1000 مرضى ولكن لدى أكثر من 1&nbsp; في&nbsp;10000 مرضى تم علاجهم.</p><p><strong>آثار نادرة جدًا </strong>تحدث لدى أقل من 1 في كل &nbsp;10000 مرضى تم علاجهم، بما في&nbsp;ذلك حالات مرضية فردية نادرة.</p><p><strong><img src="data:image/png;base64,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" alt="" width="400" height="260" vspace="0" hspace="0" border="0" style="width:400px;height:260px;margin-top:0px;margin-bottom:0px;margin-left:0px;margin-right:0px;border:0px solid black;" /></strong><br /><br />●تختفي الآثار الجانبية النادرة بسرعة عندما ينخفض معدل التسريب أو يتوقف.<br />●إذا حدثتْ صدمة تأقية )تفاعلات حساسية شديدة(، يجب إيقاف التسريب فورًا وبدء العلاج المناسب.<br />●إذا تفاقمت خطورة أي من الآثار الجانبية، أو إذا لاحظت أي اثار جانبية غير مدرجة في هذة النشرة، فيرجى إبلاغ الطبيب أو الصيدلي</p><p><br />الآثار الجانبية الأخرى التي لوحظت بعد إتاحة الألبومين البشري في السوق هي (معدل التكرار غیر متوفر من لابیانات المتاحة):<br />- تفاعلات فرط التحسس/الحساسیة<br />-فق دان حاسة الت ذوق<br />- الصداع<br />-سرعة ضربات القلب أو اضطبراات في ضب رات القل ب<br />-انخفاض ضغط الدم بمعدل غیر طبیعي<br />-ضیق التنفس أو عدم راحة في التنفس<br />- التقیؤ وتغیر إحساس الذوق والشرى<br />- الحكة والقشعریرة.</p><p><strong>- المركز الوطني للتیقظ والسلامة الدوائیة:</strong><br /><strong>الھاتف الموحد:</strong> 19999<br /><strong>البرید الإلكتروني:</strong> npc.drug@sfda.gov.sa&nbsp;<br /><strong>الموقع الإلكتروني: </strong>www.sfda.gov.sa/npc<br /><strong>بقية دول الخلیج: </strong>یرجى التواصل مع السالطت الصحیة المختصة في كل دولة.</p><p><br /><strong>إن هذا الدواء</strong><br />-الدواء مستحضر يؤثر على صحتك وإستهلاكه خلافا للتعليمات يعرضك للخطر.<br />-إتبع بدقة وصفة الطبيب وطريقة الإستعمال المنصوص عليها وتعليمات الصيدلى الذى صرفها لك.<br />-إن الطبيب والصيدلى هما الخبيران فى الدواء وبنفعه وضرره.<br />-لا تقطع مدة العلاج المحددة لم من تلقاء نفسه.<br />-لا تكرر صرف الدواء بدون إستشارة الطبیب .<br />-لا تترك الدواء فى متناول الأطفال.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>يحفظ بعيدًا عن متناول ومرأى الأطفال.<br />لا تَستخدم الألبومين البشري 200 جم/لتر تاكيدا بعد تاريخ انتهاء الصلاحية المذكور<br />على البطاقة التعريفية. يشير تاريخ انتهاء الصلاحية إلى آخر يوم من الشهر المذكور.<br />لا يخزن في درجة حرارة أعلى من 25 درجة<br />مئوية. لا يُجمَّد.<br />احفظ القنينة الزجاجية في العبوة الكرتون الخارجية لحمايتها من الضوء. بمجرد فتح العبوة،<br />يجب استخدام المحتويات على الفور.<br />لا تَستخدم الألبومين البشري 200 جم/لتر تاكيدا إذا لاحظتَ أن المحلول غائم أو يحتوي على جزيئات.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>محتويات الألبومين البشري 200 جم/لتر تاكيدا<br />المادة الفعّالة هي: الألبومين البشري<br />يحتوي كل 100 ملل على 20 جرامات من البروتين الكلي، 95 % منها على الأقل من<br />الألبومين البشري.<br />المكونات الأخرى هي: كلوريد الصوديوم، كابريلات الصوديوم، أسيتيل تريبتوفانات<br />الصوديوم، مياه للحقن.</p><p>مجموع&nbsp;أيونات الصوديوم : 100 - 130 ملمول/لتر&nbsp;</p><p><br />الشكل الدوائي للألبومين البشري 200 جم/لتر تاكيدا&nbsp;ومحتويات العبوة<br />سائل شفاف سميك قليلاً. تقريبًا عديم اللون أو أصفر أو كهرماني أو أخضر. وهو عبارة<br />عن محلول معقم للتسريب في الوريد في قنينات زجاجية سعة 50 ملل أو 100 ملل.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p>----</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>حامل حق التسویق:<br />Takeda Manufacturing Austria AG<br />Vienna, Austria<br />جھات التصنیع&nbsp;</p><p>Takeda Manufacturing Austria AG<br />Industriestra&szlig;e 67<br />1221 Vienna, Austria</p><p>Takeda Manufacturing Italia S.p.A.<br />Via G. B. Oliva, 2 56121 Loc. Ospedaletto, Pisa, Italy</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            تم الاعتماد الأخیر لھذه النشرة في مارس 2022
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Human Albumin 200 g/l Baxter
Solution for Infusion
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Human Albumin 200 g/l Baxter is a solution containing 200 g/l of total protein of which at least 95% is human albumin.
A vial of 100 ml contains 20 g of human albumin.
A vial of 50 ml contains 10 g of human albumin.
The solution is hyperoncotic and contains 100 – 130 mmol/l of total sodium.
For the full list of excipients, see section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Solution for infusion.
A clear, slightly viscous liquid; it is almost colourless, yellow, amber or green.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Restoration and maintenance of circulating blood volume where volume deficiency has been demonstrated, and use of a colloid is appropriate.<br />The choice of albumin rather than artificial colloid will depend on the clinical situation of the individual patient, based on official recommendations.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The concentration of the albumin preparation, dosage and the infusion rate should be adjusted to the patient&#39;s individual requirements.<br />Posology<br />The dose required depends on the size of the patient, the severity of trauma or illness and on continuing fluid and protein losses. Measures of adequacy of circulating volume and not plasma albumin levels should be used to determine the dose required.<br />If human albumin is to be administered, haemodynamic performance should be monitored regularly;<br />this may include:<br />- arterial blood pressure and pulse rate<br />- central venous pressure<br />- pulmonary artery wedge pressure<br />- urine output<br />- electrolyte concentration<br />- haematocrit/haemoglobin<br />- clinical signs of cardiac/respiratory failure (e.g., dyspnoea)<br />- clinical signs of increasing intra-cranial pressure (e.g., headache)<br />Method of administration<br />Human Albumin 200 g/l Baxter can be directly administered by the intravenous route, or it can also be diluted in an isotonic solution (e.g. 5 % glucose or 0.9 % sodium chloride).<br />The infusion rate should be adjusted according to the individual circumstances and the indication.<br />In plasma exchange the infusion rate should be adjusted to the rate of removal.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to albumin preparations or to any of the excipients.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Suspicion of allergic or anaphylactic type reactions requires immediate discontinuation of the injection. In case of shock, standard medical treatment for shock should be implemented.<br />Albumin should be used with caution in conditions where hypervolaemia and its consequences or haemodilution could represent a special risk for the patient. Examples of such conditions are:<br />- Decompensated cardiac insufficiency<br />- Hypertension<br />- Oesophageal varices<br />- Pulmonary oedema<br />- Haemorrhagic diathesis<br />- Severe anaemia<br />- Renal and post-renal anuria<br />The colloid-osmotic effect of human albumin 200 g/l is approximately four times that of blood plasma. Therefore, when concentrated albumin is administered, care must be taken to assure adequate hydration of the patient. Patients should be monitored carefully to guard against circulatory overload and hyperhydration.<br />200-250 g/l human albumin solutions are relatively low in electrolytes compared to the 40-50 g/l human albumin solutions. When albumin is given, the electrolyte status of the patient should be monitored (see section 4.2) and appropriate steps taken to restore or maintain the electrolyte balance. Human Albumin 200 g/l Baxter contains 100-130 mmol/l sodium. This is to be taken into consideration by patients on a controlled sodium diet.<br />Albumin solutions must not be diluted with water for injections as this may cause haemolysis in recipients.<br />If comparatively large volumes are to be replaced, controls of coagulation and haematocrit are necessary. Care must be taken to ensure adequate substitution of other blood constituents (coagulation factors, electrolytes, platelets, and erythrocytes).<br />Hypervolaemia may occur if the dosage and rate of infusion are not adjusted to the patient&acute;s circulatory situation. At the first clinical signs of cardiovascular overload (headache, dyspnoea, jugular vein congestion), or increased blood pressure, raised central venous pressure and pulmonary oedema, the infusion is to be stopped immediately.<br />5<br />Standard measures to prevent infections resulting from the use of medicinal products prepared from human blood or plasma include selection of donors, screening of individual donations and plasma pools for specific markers of infection and the inclusion of effective manufacturing steps for the inactivation/removal of viruses. Despite this, when medicinal products prepared from human blood or plasma are administered, the possibility of transmitting infective agents cannot be totally excluded. This also applies to unknown or emerging viruses and other pathogens.<br />There are no reports of virus transmissions with albumin manufactured to European Pharmacopoeia specifications by established processes.<br />It is strongly recommended that every time that Human Albumin 200 g/l Baxter is administered to a patient, the name and batch number of the product are recorded in order to maintain a link between the patient and the batch of the product.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No specific interactions of human albumin with other medicinal products are known.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The safety of Human Albumin 200 g/l Baxter for use in human pregnancy has not been established in controlled clinical trials. However, clinical experience with albumin suggests that no harmful effects on the course of pregnancy, or on the foetus and the neonate are to be expected.<br />The effects of Albumin on fertility have not been established in controlled clinical trials.<br />No animal reproduction studies have been conducted with Human Albumin 200 g/l Baxter.<br />Experimental animal studies are insufficient to assess the safety with respect to reproduction, development of the embryo or foetus, the course of gestation and peri-and postnatal development.<br />However, human albumin is a normal constituent of human blood.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No effects on ability to drive and use machines have been observed.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Frequency has been evaluated using the following criteria: very common (&ge;1/10), common (&ge;1/100 to &lt;1/10), uncommon (&ge;1/1,000 to &lt;1/100), rare (&ge;1/10,000 to &lt;1/1,000), and very rare (&lt;1/10,000), not known (cannot be estimated from the available data).<br />Very Common<br />Common<br />Uncommon<br />Rare<br />Very rare<br />Immune system disorders<br />anaphylactic shock<br />Gastrointestinal disorders<br />nausea<br />Skin and subcutaneous tissue disorders<br />flushing, skin rash<br />General disorders and administration site conditions<br />fever<br />6<br />In cases of severe reactions, the infusion should be stopped and an appropriate treatment should be initiated.<br />In post-marketing surveillance the following adverse events have been reported. These events are listed by MedDRA System Organ Class, then by Preferred Term in order of severity.<br />Immune System Disorders: Anaphylactic reaction, Hypersensitivity/Allergic reactions<br />Nervous System Disorders: Headache, Dysguesia<br />Cardiac Disorders: Myocardial infarction, Atrial fibrillation, Tachycardia<br />Vascular Disorders: Hypotension<br />Respiratory, Thoracic, and Mediastinal Disorders: Pulmonary edema, Dyspnea<br />Gastrointestinal Disorders: Vomiting<br />Skin and Subcutaneous Tissue Disorders: Urticaria, Pruritis<br />General Disorders and Administration Site Conditions: Chills<br />There are no data available on adverse reactions from Baxter-sponsored clinical trials conducted with Albumin (Human).<br />For safety with respect to transmissible agents, see section 4.4.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Hypervolaemia may occur if the dosage and infusion rate are too high. At the first clinical signs of cardiovascular overload (headache, dyspnoea, jugular vein congestion), or increased blood pressure, raised central venous pressure, and pulmonary oedema, the infusion should be stopped immediately and the patient&acute;s haemodynamic parameters carefully monitored.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: plasma substitutes and plasma protein fractions, ATC code: B05AA01.<br />Human albumin accounts quantitatively for more than half of the total protein in the plasma and represents about 10 % of the protein synthesis activity of the liver.<br />Physico-chemical data: Human Albumin 200 g/l Baxter has a corresponding hyperoncotic effect.<br />The most important physiological functions of albumin result from its contribution to the oncotic pressure of the blood and its transport function. Albumin stabilizes circulating blood volume and is a carrier of hormones, enzymes, medicinal products and toxins.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Under normal conditions the total exchangeable albumin pool is 4 - 5 g/kg bodyweight, of which 40 to 45 % is present intravascularly and 55 to 60 % in the extravascular space. Increased capillary permeability will alter albumin kinetics and abnormal distribution may occur in conditions such as severe burns or septic shock.<br />Under normal conditions, the average half life of albumin is about 19 days. The balance between synthesis and breakdown is normally achieved by feedback regulation. Elimination is predominantly intracellular and due to lysosome proteases.<br />In healthy subjects, less than 10 % of infused albumin leaves the intravascular compartment during the first two hours following infusion. There is considerable individual variation in the effect on<br />plasma volume. In some patients the plasma volume can remain increased for some hours. However, in critically ill patients, albumin can leak out of the vascular space in substantial amounts at an unpredictable rate</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Under normal conditions the total exchangeable albumin pool is 4 - 5 g/kg bodyweight, of which 40 to 45 % is present intravascularly and 55 to 60 % in the extravascular space. Increased capillary permeability will alter albumin kinetics and abnormal distribution may occur in conditions such as severe burns or septic shock.<br />Under normal conditions, the average half life of albumin is about 19 days. The balance between synthesis and breakdown is normally achieved by feedback regulation. Elimination is predominantly intracellular and due to lysosome proteases.<br />In healthy subjects, less than 10 % of infused albumin leaves the intravascular compartment during the first two hours following infusion. There is considerable individual variation in the effect on<br />plasma volume. In some patients the plasma volume can remain increased for some hours. However, in critically ill patients, albumin can leak out of the vascular space in substantial amounts at an unpredictable rate</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Sodium Caprylate: 16 mmol/l (2.7 g/l)<br />Sodium N-Acetyltryptophanate: 16 mmol/l (4.3 g/l)<br />Sodium Chloride: 3.0 g/l<br />Water for Injection: ad 1 l</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Human albumin must not be mixed with other medicinal products (except the recommended diluents mentioned in section 6.6), whole blood and packed red cells. Further human albumin should not be mixed with protein hydrolysates (e.g. parenteral nutrition) or solutions containing alcohol since these combinations may cause the proteins to precipitate.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                36 months
After opening the product should be used immediately.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not store above 25&deg;C.<br />Do not freeze.<br />Store in the original package in order to protect from light.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>50 ml of solution in a vial (type II glass) with a bromobutyl rubber stopper &ndash; pack size of 1 or 70.<br />100 ml of solution in a vial (type II glass) with a bromobutyl rubber stopper &ndash; pack size of 1 or 56.<br />Not all pack sizes may be marketed.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The solution can be directly administered by the intravenous route or it can also be diluted in an isotonic solution (e.g. 5 % glucose or 0.9% sodium chloride). Albumin solutions must not be diluted with water for injections as this may cause haemolysis in recipients. If large volumes are administered, the product should be warmed to room or body temperature before use. Do not use solutions which are cloudy or have deposits. This may indicate that the protein is unstable or that the solution has become contaminated. Do not use unless seal is intact. If leaks are found, discard. Once the container has been opened, the contents should be used immediately. Any unused product should be disposed of in accordance with local requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Baxter AG, Austria-Vienna
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                01-10-2009
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>